Note: The study medication and placebo were provided by Pfizer.
a b s t r a c t
Non-cardiac chest pain (NCCP) is a common and distressing condition. Prior studies suggest that psychotropic medication or pain coping skills training (CST) may benefit NCCP patients. To our knowledge, no clinical trials have examined the separate and combined effects of CST and psychotropic medication in the management of NCCP. This randomized clinical trial examined the separate and combined effects of CST and antidepressant medication (sertraline) in participants with non-cardiac chest pain. A sample of individuals diagnosed with NCCP was randomly assigned to one of four treatments: (1) CST plus sertraline (CST + sertraline), (2) CST plus placebo (CST + placebo), (3) sertraline alone, or (4) placebo alone. Assessments of pain intensity, pain unpleasantness, anxiety, pain catastrophizing, depression, and physical disability were collected prior to treatment, and at 10-and 34-weeks following randomization. Data analyses revealed that CST and sertraline either alone or in combination significantly reduced pain intensity and pain unpleasantness. The combination of CST plus sertraline may have the greatest promise in that, when compared to placebo alone, it not only significantly reduced pain but also pain catastrophizing and anxiety. Overall, these findings support the importance of further research on the effects of CST and sertraline for non-cardiac chest pain. Ó 2011 Published by Elsevier B.V. on behalf of International Association for the Study of Pain.
Introduction
Over 50% of patients who are referred for evaluation of chest pain are diagnosed as having non-cardiac chest pain (NCCP) [4, 36, 39] , i.e., angina-like chest pain in the absence of coronary artery disease [19, 20] . Despite a negative work-up and an excellent medical prognosis, over 65% of NCCP patients report persistent pain [4, 39, 43, 45] . Research has shown that these patients also report high levels of anxiety, depression, catastrophic thinking, and physical disability [17, 65, 69] .
The conventional medical approach to NCCP consists of a negative medical evaluation coupled with reassurance that they do not have a cardiac condition. Many NCCP patients who receive this approach remain concerned and continue to report persistent and disabling pain [4, 39, 43, 45] . Thus, there has been growing interest in novel treatment approaches. Two promising approaches that have been developed largely independent of each other are coping skills training (CST) and antidepressant medications. CST is based on cognitive-behavioral principles and views factors such as beliefs about pain as having a major impact on non-cardiac chest pain and distress [31, 33, 38, 40, 50, 51, 61, 65, 66] . CST protocols systematically teach patients cognitive and behavioral strategies for managing pain. CST trials for NCCP show promising results [16, 26, 27, 33, 37, 40, [64] [65] [66] . Klimes et al. [33] found that NCCP patients who received CST showed significant decreases in pain, depression, and activity avoidance [33] . Other studies have reported that CST can produce significant decreases in pain and other outcome measures (anxiety, depression, well being, or activity limitations) [26, 40, 65, 66] . Although these studies suggest CST has promise in the treatment of NCCP, they generally are limited by small sample sizes, lack of long-term follow-up, and no control or active comparison groups.
Antidepressant medications have been shown to reduce pain in patients with NCCP. Cannon et al. [13] reported that NCCP patients
